Nalaganje...
Varenicline in the treatment of tobacco dependence
Varenicline, a partial agonist of α(4)β(2) nicotinic acetylcholine receptors, is the most recently approved drug for smoking cessation. This paper reviews the outcomes of Phase 2 and Phase 3 clinical trials that assess the efficacy of varenicline in comparison to placebo and other smoking cessation...
Shranjeno v:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dove Medical Press
2008
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2518383/ https://ncbi.nlm.nih.gov/pubmed/18728741 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|